IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV) and Idexx Laboratories ...

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)

In a report released today, Glen Santangelo from Barclays maintained a Buy rating on Idexx Laboratories, with a price target of $710.00. According ...

Idexx Laboratories (IDXX) Receives a Buy from Barclays

Citi analyst Daniel Grosslight maintained a Hold rating on Idexx Laboratories today and set a price target of $670.00. According to TipRanks, Gross...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	IDXX	$550.96	-2.82%	530.33K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	IDXX	$550.96	-2.8%	530.33K
3
4
5
6

IDXX

Get IDEXX Laboratories, Inc. Data in Excel

Get IDEXX Laboratories, Inc. Data in Excel